Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

ELAB

PMGC (ELAB)

PMGC Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ELAB
DataHoraFonteTítuloCódigoCompanhia
10/02/202502:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ELABPMGC Holdings Inc
07/02/202518:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELABPMGC Holdings Inc
04/02/202510:00GlobeNewswire Inc.Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1NASDAQ:ELABPMGC Holdings Inc
31/01/202518:19Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ELABPMGC Holdings Inc
31/01/202512:33GlobeNewswire Inc.PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology CompaniesNASDAQ:ELABPMGC Holdings Inc
30/01/202510:00GlobeNewswire Inc.Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1NASDAQ:ELABPMGC Holdings Inc
27/01/202511:00GlobeNewswire Inc.PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional InvestorsNASDAQ:ELABPMGC Holdings Inc
27/01/202508:03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ELABPMGC Holdings Inc
24/01/202510:00GlobeNewswire Inc.Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity SymposiumNASDAQ:ELABPMGC Holdings Inc
16/01/202510:31GlobeNewswire Inc.PMGC Holdings Inc. Announces Closing of Elevai Skincare DivestitureNASDAQ:ELABPMGC Holdings Inc
15/01/202511:30GlobeNewswire Inc.PMGC Holdings Inc. Announces Name Change of Wholly Owned SubsidiariesNASDAQ:ELABPMGC Holdings Inc
02/01/202517:55GlobeNewswire Inc.PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth StrategyNASDAQ:ELABPMGC Holdings Inc
02/01/202510:00GlobeNewswire Inc.Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care ProductsNASDAQ:ELABPMGC Holdings Inc
20/12/202421:30GlobeNewswire Inc.Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to NevadaNASDAQ:ELABPMGC Holdings Inc
20/12/202409:30GlobeNewswire Inc.Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to NevadaNASDAQ:ELABPMGC Holdings Inc
09/12/202410:00GlobeNewswire Inc.Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle PreservationNASDAQ:ELABPMGC Holdings Inc
06/12/202409:30GlobeNewswire Inc.Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care MarketNASDAQ:ELABPMGC Holdings Inc
04/12/202410:00GlobeNewswire Inc.Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare DivisionNASDAQ:ELABPMGC Holdings Inc
25/11/202419:18Edgar (US Regulatory)Form DEFR14C - Revised information statement materials, definitiveNASDAQ:ELABPMGC Holdings Inc
22/11/202420:23GlobeNewswire Inc.Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing ComplianceNASDAQ:ELABPMGC Holdings Inc
22/11/202419:11Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:ELABPMGC Holdings Inc
22/11/202419:00GlobeNewswire Inc.Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to ReassessNASDAQ:ELABPMGC Holdings Inc
22/11/202410:11Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:ELABPMGC Holdings Inc
14/11/202416:35GlobeNewswire Inc.CORRECTION - Elevai Labs Inc.NASDAQ:ELABPMGC Holdings Inc
14/11/202411:08GlobeNewswire Inc.Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business UpdateNASDAQ:ELABPMGC Holdings Inc
04/11/202419:45GlobeNewswire Inc.Elevai Labs Inc. Announces Update and Extension of Pending Offer to ExchangeNASDAQ:ELABPMGC Holdings Inc
22/10/202410:54GlobeNewswire Inc.Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of ObesityNASDAQ:ELABPMGC Holdings Inc
21/10/202408:30GlobeNewswire Inc.Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of ObesityNASDAQ:ELABPMGC Holdings Inc
04/10/202418:26Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:ELABPMGC Holdings Inc
04/10/202418:08GlobeNewswire Inc.Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred StockNASDAQ:ELABPMGC Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ELAB